Dr. Kamal Kabakibou and his medical practice, Kamal Kabakibou, M.D., P.C., will pay $3.5 million to resolve False Claims Act and the Controlled Substances Act violations related to allegations of billing for medically unnecessary testing and pre-signing opioid prescriptions, the Justice Department announced Thursday.
According to the DOJ, Dr. Kabakibou performed medically unnecessary and duplicative laboratory testing on patients and submitted claims for those tests to federal health insurance programs. When Dr. Kabakibou traveled abroad, he pre-signed prescriptions for his nurse practitioners to dispense, including Schedule II controlled substances like opioids, which could not be dispensed by unsupervised nurse ...
AI-powered legal analytics, workflow tools and premium legal & business news.
Log in to keep reading or access research tools.
The nonpartisan Congressional Budget Office has warned that Medicaid cuts in Republicans’ “One Big Beautiful Bill Act” would cause millions of people to lose health coverage. Right-wing media figu...